
New Frontiers in the Treatment of DMD Across the Age Spectrum
Released On
April 25, 2025
Expires On
April 24, 2026
Media Type
Internet
Completion Time
60 minutes
Specialty
Neurology, Pediatrics
Topic(s)
Duchenne Muscular Dystrophy
Providers/Grant Support
This activity is supported in part by an independent education grant from Sarepta Therapeutics.
Credit Available
- Physicians — maximum of 1.0 AMA PRA Category 1 Credit™
All other health care professionals completing this course will be issued a statement of participation.
Target Audience
This activity is intended for health care professionals involved in the management of patients with Duchenne muscular dystrophy (DMD), including neurologists and other neuromuscular specialists.
Program Overview
Discover how to navigate the expanding landscape of DMD treatments by learning practical strategies from leading experts as they discuss real-world patient cases, the latest clinical trial insights, and best practices for managing patients of all ages. Empower your decision-making and enhance your patient care. Start today to stay at the forefront of DMD treatment advancements!
Learning Objectives
Upon completion of this activity, participants should be better able to:
- Evaluate real-world, case-based scenarios for patients with DMD to address considerations when assessing candidacy for gene therapy across the age spectrum
- Assess the latest clinical trial data for DMD gene therapy treatments to help inform clinical decision-making
- Describe best practices for ongoing monitoring of patients at various ages who have received gene therapy for DMD
Faculty

Crystal Proud, MD (Chair)
Pediatric Neurologist
Children’s Hospital of the King’s Daughters
Norfolk, VA

John Brandsema, MD
Attending Physician
Neuromuscular/General Neurology & Electromyography
Children's Hospital of Philadelphia
Philadelphia, PA

Omer Abdul Hamid, MD
Pediatric Neurologist
Nemours Children’s Health
Orlando, FL
Accreditation Statement

In support of improving patient care, The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the health care team.
Credit Designation
Physicians

The France Foundation designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
All other health care professionals completing this course will be issued a statement of participation.
Disclosures of Conflicts of Interest

Instructions for Participation and Credit
There are no fees for participating in and receiving CME credit for this enduring activity. To receive CME credit participants must:
- Read the CME/CE information and faculty disclosures
- Participate in the online activity
- Submit the evaluation form
Certificates will be emailed to participants.
Course Viewing Requirements
Supported Browsers (Desktop/Mobile)
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, and Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above
Supported Phones & Tablets
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above
Disclosure of Unlabeled Use
The France Foundation requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.
Disclaimer
This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Contact Information
If you have questions about this CME/CE activity, please contact The France Foundation at 860-434-1650 or [email protected] .